0.00Open0.01Pre Close0 Volume3.64K Open Interest310.00Strike Price0.00Turnover447.31%IV15.93%PremiumApr 17, 2025Expiry Date0.00Intrinsic Value100Multiplier-9DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0096Delta0.0084Gamma36871.00Leverage Ratio-20.6594Theta0.0000Rho-355.64Eff Leverage0.0002Vega
Strategy Stock Discussion
Need a quick update on this week's events? Check out moomoo's fresh earnings & economic calendars to start this week!
For more details, check out the earnings calendar and economic calendar!
This week, various companies including $Meta Platforms (META.US)$, $Microsoft (MSFT.US)$, $Apple (AAPL.US)$, $Amazon (AMZN.US)$ and $Strategy (MSTR.US)$ are releasing their earnings. How will the market react to the companies' resul...
As Bitcoin claws its way back to $94,000, reclaiming its footing after a volatile first quarter, investors are once again confronting a critical question: Why allocate to digital assets in an increasingly uncertain macro environment? The answer lies in Bitcoin's unique properties as a non-correlated, scarce, and institutionally validated asset, a narrative rein...
Institutional estimates suggest that Strategy is poised to report Q1 revenue of $117 millio...
🏢 What Does MicroStrategy Do?
MicroStrategy is a business intelligence (BI) software company, but what makes it stand out today is its massive investment in Bitcoin.
So, it operates on two fronts:
1. Core business: Selling data analytics and cloud-based BI software to enterprises.
2. Bitcoin strategy: Acting like a “corporate Bitcoin vault”, buying and holding Bitcoin as part of its long-term finan...
$Tesla (TSLA.US)$ surged 9.8% to lead the Magnificent 7, driven by positive trade developments and a U.S. government decision on Thursday to accelerate self-driving car adoption. TSLA's significant investments in autonomous "robotaxi" technology further bolstered the gain.
The most traded calls are contracts of $285 strike price that expire on Apr 25 and the total volume reaching 348,189 wi...
No comment yet